InterCure Stock

InterCure PEG

PEG Ratio (Price/Earnings-to-Growth) of InterCure (INCR.TA) as of Sep 7, 2026.

PEG

0.00

Last updated:

PEG Ratio (Price/Earnings-to-Growth) of InterCure is 2026 0.00 . PEG Ratio (Price/Earnings-to-Growth) of InterCure was 2025 0.00 . It decreases by % lower compared to the previous year.
Access this data via the Eulerpool API

InterCure Stock analysis

What does InterCure do? InterCure Ltd. is a global company in the medical technology industry that focuses on the development, production, and distribution of innovative solutions for the diagnosis and treatment of chronic diseases. The company was founded in Israel in 2000 and is headquartered in Lod. InterCure is one of the most popular companies on Eulerpool.

Frequently Asked Questions about InterCure stock

On Eulerpool you can find the complete historical development of PEG Ratio (Price/Earnings-to-Growth) InterCure since 2006 – with annual values, charts, and detailed analysis.

The PEG ratio adjusts the P/E ratio by the expected earnings growth rate. A PEG below 1 may indicate an undervalued stock relative to its growth potential.

PEG = P/E Ratio / Expected Annual EPS Growth Rate

To evaluate PEG Ratio (Price/Earnings-to-Growth)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for PEG Ratio (Price/Earnings-to-Growth).

A 'good' varies by industry and company stage. On Eulerpool, you can compare PEG Ratio (Price/Earnings-to-Growth)'s InterCure with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — InterCure

All Key Metrics — InterCure